Stock market technical analysis forecast | Nasdaq trend research for trading investing | 401k
trading penny stock breakout day investing
Skip Navigation Links
    Home
    •   About US
    Market Activity
    World Indices
    Market Watch
    Customer Service
    Learning Center
    Economic Event
    Login


Join Now




Advertise 2 ۩  Daily market forecast

Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research

MSFT Microsoft Co
SectorSoftware
RecommendationsBuy
Buy Near21.31
Stop Loss20.91
Posted Date6/5/2009 1:32:46 AM
First resistance22.53
Second resistance23.50
Third resistance26.67
First Support20.91
Second Support19.54
Comments
6/4/2009 12:27:56 PM0) Technical Stock research Yesterday Microsoft (MSFT) given a breakout of reverse head and shoulder pattern beside that ADX also indicating up word move for Microsoft (MSFT), rate of change (ROC) got upward momentum with increasing relative price index (RSI). Stock investing with chart pattern Head and solder is a best chaise and as per technical view Microsoft (MSFT) in a short term up trend
1) You can use Microsoft for day trading also.

As per head and shoulder theory for Microsoft our up side target is $26.67
2) So built position with target $26.67 and consider base line as a stop loss ($20.91)
MSFT       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Twilio's Secret Growth Advantage: Its Own Customers
(Thu, 26 Nov 2020 12:10:00 +0000)
A successful new offering shows how the tech stock gets ahead by listening to the people who use its products.
3 Index Funds Perfect for Your IRA
(Thu, 26 Nov 2020 12:01:00 +0000)
Whether you're a 20-something who's just starting to invest or approaching your retirement years, investing your IRA in index funds is a sound strategy. You get automatic diversification, low fees, and the potential for huge growth over the long run.
10 Stocks to Be Thankful for This Thanksgiving
(Thu, 26 Nov 2020 12:00:00 +0000)
Apple, Amazon.com, Microsoft, and a number of other tech stocks were the biggest drivers of the S&P 500’s gains so far this year.
The S&P 500 Could Jump 20% Next Year. Three Strategists Explain Why.
(Thu, 26 Nov 2020 11:00:00 +0000)
The stock market could continue roaring in the next year because of a powerful combination of Covid-19 vaccines and low interest rates.
Nintendo Adds Sharp as Assembler of Popular Switch Console
(Thu, 26 Nov 2020 03:19:54 +0000)
(Bloomberg) -- Nintendo Co. has added Sharp Corp. as an assembler of its Switch console, according to people directly involved in the matter, as it works to stabilize production and hedge against U.S.-China trade tensions.The video game giant has struggled to produce enough units for most of this year as the hit game Animal Crossing: New Horizons and stuck-at-home consumers fueled demand. While the coronavirus outbreak hurt production early on, Nintendo President Shuntaro Furukawa said this month that output has returned to normal and the Switch is now made in Malaysia, in addition to existing China and Vietnam locations.Read More: Nintendo Climbs After Boosting Forecast by 50% on Gaming DemandThat Malaysia factory is owned by Sharp, said the people, who asked not to be identified because the information isn’t public. Nintendo’s main assembly partner Foxconn Technology Co., a key unit of Foxconn Technology Group, owns a Sharp stake and helped connect the two Japanese companies, they added. Sharp continues to operate separately from its Taiwanese owner and its stock will be added to the Nikkei 225 Stock Average next week after a four-year absence.Sharp shares were up as much as 2.8% Thursday, outperforming the benchmark TOPIX and reaching their highest point since February, while Nintendo rose as much as 3.5%.Nintendo asked Foxconn Tech during the Trump era to provide alternative manufacturing sites outside of China to hedge against the trade war, according to one of the people, and the company ended up directing some Switch orders to Sharp as the Japanese company had extra capacity in Malaysia. The production volume in the Southeast Asia site is limited, the person said.Nintendo’s Furukawa has said those assembly lines aren’t yet running at full capacity and the first batch from them is about to hit store shelves soon.A Sharp representative declined to comment, while a Nintendo spokesman declined to confirm any details beyond the president’s earlier public comments.Switch assemblers plan to operate at maximum capacity through the end of this year, eschewing the typical December lull that follows the fulfillment of holiday demand. That suggests Nintendo, in the current quarter, may end up shipping more than the 10.8 million Switch units it managed in the October-December period last year.Read More: Nintendo Said to Boost Switch Production by Another 20%Nintendo has been diversifying its supply chain since before the Covid-19 era and its chief said at this month’s press conference that the Malaysia addition is part of the effort. Osaka-based Sharp has a history of working with Nintendo, having once assembled the Famicom console and later provided key components for the 3DS handheld device. The bulk of Switch production continues to be handled by Foxconn Tech in China.Switch sales momentum kept up in October, according to the Nintendo president, and the hotly anticipated debuts of new consoles from Sony Corp. and Microsoft Corp. in November were marred by severely limited launch-day supplies. Nintendo is expected to raise its fiscal-year sales target from the current 24 million when it next reports quarterly results, with David Gibson, chief investment adviser at Astris Advisory Japan, forecasting 26.4 million total sales for the period ending March 31.Read More: Sony, Microsoft Consoles Struggle With Thin Launch-Day StockReleased in 2017, the Switch has sold 68.3 million units as of Sept. 30 and its lifetime sales are on track to exceed 100 million units. The company has expressed confidence in the beefed-up games lineup it has in store for 2021. Bloomberg News has also reported Nintendo plans an upgraded hardware revision, likely with 4K graphics support, to help extend the Switch’s life cycle.Read More: Nintendo Plans New Switch Games, Extending Console’s Life Cycle(Updates with market reaction in fourth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
ARRS ARRIS Group Inc Com
SectorTechnology : Communications Equipment
RecommendationsBuy
Buy Near7.32
Stop Loss6.62
Posted Date1/1/2009 12:00:00 AM
First resistance8.77
Second resistance9.62
Third resistance9.75
First Support7.32
Second Support7.19
Comments
1/1/2009 9:03:06 PM0) ARRIS Group Inc Com (ARRS), yesterday announced that its Advanced Advertising manager solution has successfully interconnected with systems of several leading Advanced Advertising Decision Service and Campaign manager providers at its labs in Beaverton and Stock given a breakout with high volume
1) Again given a buy signal with rising moving average
2) Stockhastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, Stock analysis and fundamental research ARRIS Group Inc Com (ARRS) Stock looks good candidate for breakout Stock investing as well as you can add in portfolio investment
3) Recently Stock given a breakout with rising moving average and also Stockhastic and Rate of change (ROC) given a buy signal
4) ARRIS Group Inc Com (ARRS) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
5) Due to Stock market and economic condition keep tight stop loss on all position
6) You can buy this Stock near $7.32
10/16/2005 12:00:00 AM0) ARRIS Group Inc Com (ARRS), yesterday announced that its Advanced Advertising manager solution has successfully interconnected with systems of several leading Advanced Advertising Decision Service and Campaign manager providers at its labs in Beaverton and Stock given a breakout with high volume
1) Again given a buy signal with rising moving average
2) Stockhastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, Stock analysis and fundamental research ARRIS Group Inc Com (ARRS) Stock looks good candidate for breakout Stock investing as well as you can add in portfolio investment
3) Recently Stock given a breakout with rising moving average and also Stockhastic and Rate of change (ROC) given a buy signal
4) ARRIS Group Inc Com (ARRS) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
5) Due to Stock market and economic condition keep tight stop loss on all position
6) You can buy this Stock near $7.32
0) Sell sort at 12 with 12.47 stop loss
ARRS       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
AHL Aspen Insurance Holdings Limit
SectorFinancial : Insurance
RecommendationsBuy
Buy Near22.93
Stop Loss22.15
Posted Date1/1/2009 12:00:00 AM
First resistance24.34
Second resistance27.50
Third resistance28.00
First Support22.93
Second Support22.56
Comments
1/1/2009 9:04:46 PM0) Aspen Insurance Holdings Limit (AHL) recently announced that its subsidiary, Aspen Insurance UK Limit, authorized by the Regulation Authority to operate as a branch insurer to underwrite general insurance business in Australia and also announced that A.M
1) Best has affirmed the AAA financial strength ratings of Aspen Bermuda subsidiary, Aspen Insurance Limit and its UK subsidiary, Aspen Insurance UK Limit
2) Again given a buy signal with rising moving average
3) Stockhastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, Stock analysis and fundamental research this Stock looks good candidate for breakout Stock investing as well as you can add in portfolio investment
4) Aspen Insurance Holdings Limit (AHL) Stock given a breakout with high volume and rising moving average and also Stockhastic & Rate of change ROC) given a buy signal
5) Aspen Insurance Holdings Limit (AHL) Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
6) Due to Stock market and economic condition keep tight stop loss on all position
7) You can buy this Stock near $22.93
AHL        Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Aspen Declares Dividends on Preference Shares
(Tue, 26 May 2020 20:15:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE:AHL) announced today that the Board of Directors has declared the following dividends on its Preference Shares:
Angostura Hosts Interactive Live Series on Instagram to Support International Bartender Community
(Thu, 09 Apr 2020 19:48:00 +0000)
This week the House of Angostura® launched a new live & interactive social media campaign through Instagram®, titled HouseLockDown series, which aims to build and share moral support to the international bar community, those working in hospitality as well as sharing some creative ideas to budding at-home Bartenders.
Aspen Announces Filing of Annual Report on Form 20-F
(Mon, 06 Apr 2020 21:08:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE: AHL) has today filed its annual report on Form 20-F for the year ended December 31, 2019 with the U.S. Securities and Exchange Commission ("SEC").
Aspen Appoints Kevin Chidwick as Group Chief Financial Officer
(Mon, 16 Mar 2020 22:10:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE: AHL) announced today that Kevin Chidwick has been appointed Group Chief Financial Officer, effective May 1, 2020.
Aspen Reports Results for the Twelve Months Ended December 31, 2019
(Mon, 16 Mar 2020 22:02:00 +0000)
Aspen Insurance Holdings Limited ("Aspen") (NYSE: AHL) reported results today for the twelve months ended December 31, 2019.
CBST CUBIST PHARMACEUTICALS INC COM
SectorBiotechnology & Drugs
RecommendationsBuy
Buy Near23.54
Stop Loss17.82
Posted Date11/2/2008 12:00:00 AM
First resistance25.55
Second resistance26.77
Third resistance 
First Support23.34
Second Support17.82
Comments
11/2/2008 9:05:00 PM0) Biotechnology company Cubist Pharmaceuticals Inc.com (CBST) Stock given a breakout on 10/31/08 with good volume again many technical indicators also have given a buy signal, with rising moving average
1) Stockhastic and ADX also given a buy signal
2) Cubist Pharmaceuticals Inc.com (CBST) announced on 10/16/08 its third-quarter profit jumped 40 percent and Revenue increased 41 percent
3) Cubist Pharmaceuticals Inc.com (CBST) is a drug discovery company
4) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Cubist Pharmaceuticals Inc.com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
5) Due to Stock market and economic condition keep tight stop loss on all position
6) You can buy this Stock near $23.54
CBST       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
PETS PETMED EXPRESS INC COM
SectorRetail (Drugs)
RecommendationsBuy
Buy Near16.00
Stop Loss14.20
Posted Date11/2/2008 12:00:00 AM
First resistance17.72
Second resistance19.50
Third resistance 
First Support15.97
Second Support14.20
Comments
11/2/2008 9:06:46 PM0) PetMed Express Inc.com (PETS) Stock has given a buy signal, with rising moving average
1) Stockhastic and ADX also given a buy signal
2) PetMed Express Inc.com (PETS) announced on 10/20/08 its fiscal second-quarter profit climbed 29 percent PetMed Express Inc.com (PETS) is a pet-medication delivery company
3) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. PetMed Express Inc.com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
4) Due to Stock market and economic condition keep tight stop loss on all position
5) You can buy this Stock near $16.00
PETS       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Walmart Expands In One Of The Hottest Consumer Trends Right Now
(Thu, 12 Nov 2020 21:01:31 +0000)
Walmart is offering new pet services as the retail giant capitalizes on a pandemic-related trend: increased pet ownership.
PetMed Express, Inc. (NASDAQ:PETS) Stock Goes Ex-Dividend In Just Three Days
(Mon, 02 Nov 2020 12:55:02 +0000)
Readers hoping to buy PetMed Express, Inc. (NASDAQ:PETS) for its dividend will need to make their move shortly, as the...
PetMed Express, Inc. (NASDAQ:PETS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
(Thu, 29 Oct 2020 14:18:22 +0000)
Last week saw the newest second-quarter earnings release from PetMed Express, Inc. (NASDAQ:PETS), an important...
PetMed Express Inc (PETS) Q2 2020 Earnings Call Transcript
(Mon, 26 Oct 2020 15:00:26 +0000)
Welcome to the PetMed Express Incorporated, doing business as 1-800-PetMeds, Conference Call to Review the Financial Results for the Second Fiscal Quarter for the quarter ended on September 30, 2020. The increases in sales were due to increases in reorder sales for the quarter, and increases for both new order and reorder sales for the six months.
A Look At The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)
(Mon, 26 Oct 2020 13:07:45 +0000)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of PetMed Express, Inc...
WSBC WESBANCO INC COM
SectorFinancial
RecommendationsBuy
Buy Near27.18
Stop Loss25.46
Posted Date11/2/2008 12:00:00 AM
First resistance28.90
Second resistance30.00
Third resistance31.45
First Support25.46
Second Support22.56
Comments
11/2/2008 9:07:49 PM0) WesBanco, Inc
1) com (WSBC) Stock has given a buy signal, with rising moving average
2) Stockhastic and ADX also given a buy signal
3) WesBanco, Inc
4) com (WSBC) announced on 10/21/08 its net income increased 17.9% during the third quarter of 2008 WesBanco, Inc
5) com (WSBC) is a multi-state bank holding company
6) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. WesBanco, Inc
7) com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
8) Due to Stock market and economic condition keep tight stop loss on all position
9) You can buy this Stock near $27.18
WSBC       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Is WesBanco (WSBC) Stock a Solid Choice Right Now?
(Tue, 24 Nov 2020 14:48:02 +0000)
WesBanco (WSBC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
WesBanco Declares Quarterly Cash Dividend to Its Shareholders
(Wed, 18 Nov 2020 21:15:00 +0000)
WesBanco, Inc. (Nasdaq:WSBC), a diversified, multi-state bank holding company, announced today that its Board of Directors has declared a quarterly cash dividend of $0.32 per share to be paid to its holders of common stock. The dividend will be payable on January 2, 2021 to shareholders of record on December 11, 2020, and represents an annualized cash dividend rate of $1.28 per common share.
6 Bank Stocks That Could Be Winners in 2021
(Wed, 11 Nov 2020 20:13:00 +0000)
Hovde Group highlights six banks that are more likely to be able to release their reserves on improving credit quality and eventually see a boost to earnings.
Could The WesBanco, Inc. (NASDAQ:WSBC) Ownership Structure Tell Us Something Useful?
(Wed, 04 Nov 2020 18:45:33 +0000)
The big shareholder groups in WesBanco, Inc. (NASDAQ:WSBC) have power over the company. Large companies usually have...
3 ‘Strong Buy’ Stocks With at Least 5% Dividend Yield
(Tue, 03 Nov 2020 22:57:15 +0000)
Americans went to the polls today under the shadow of a resurging pandemic, with a substantial increase in cases nationwide and the number of people hospitalized with COVID-19 reaching record highs in a growing number of states. Meanwhile, it's still unclear what a second stimulus package from the federal government may look like and how long it will be until that arrives.To add fuel to this, there are several European governments that are starting to lock down their respective countries all over again in order to prevent the further spread of COVID.With all of this uncertainty, what is an investor to do? Adding dividend stocks as a potential defensive play can add protection to your portfolio.We’ve opened up the TipRanks database, finding three stocks whose profile justifies the entry risk in today’s conditions. All three offer at least 5% dividend yield, and backed by several analysts, enough to earn a “strong buy” consensus rating. Let's take a closer loo. AbbVie (ABBV)AbbVie is a pharmaceutical company, one of Big Pharma’s major names. Pharmaceutical and biotech companies are known for their combination of high risk and high reward potential. The rewards and risks are both typified in Humira, the company’s successful immunosuppressive anti-inflammatory drug. Humira is expected to bring in ~40% of AbbVie’s 2020 drug division revenues – but with an expired patent, competition is growing. Against this backdrop, AbbVie had acquired another pharmaceutical company, Allergan, that increased top-line revenues by $16B for AbbVie while the combined companies bring in $2B in synergies. The acquisition showed investors that AbbVie is simultaneously looking beyond their holdings in Humira.Future guidance has revenues moving higher along with earnings. Guidance on revenues has been increased to $10.47 - $10.49 EPS versus $10.35 - $10.45 EPS. The earnings were enough to allow management to raise the dividend from $1.18 to $1.30. At $5.20 annualized, this dividend yields 6.11%, more than 2.5x the average dividend found among S&P listed companies. The payout ratio of 49.7% indicates that the dividend is safe – current earnings easily cover it, and there is plenty of room for further growth.Covering the stock for SVB Leerink, analyst Geoff Porges noted, "AbbVie had another strong beat and raise in Q3, demonstrating their very resilient business during the pandemic and highlighting strong growth prospects for their core business. Guidance was once again raised, and the company’s comments about mid- to long-term revenue potential for their core products were very positive [...] AbbVie’s valuation seems very attractive at today’s price, and we see substantial upside potential as we expect the stock to revert to its more normalized absolute and relative multiple after the current election blues are resolved in the new year."To this end, Porges rates AbbVie an Outperform (i.e. Buy) along with a $119 price target. This figure suggests a potential upside of 35% over the next year. (To watch Porges track record, click here)Overall, Wall Street is very bullish on Abbvie. There are a total of 8 ratings; 7 Buys and 1 Hold -- all add up to a Strong Buy consensus rating. The stock’s current price is $88 and the average price target is $110.13 suggesting 25% one-year upside move. (See ABBV stock analysis on TipRanks)WesBanco (WSBC)Next up is WesBanco, a bank operating in the region of western Pennsylvania, West Virginia, Ohio and Kentucky with 236 branches. The pandemic has struck financial institutions because of loans in default. Loan losses, or their potential, have forced banks and lenders to start building up reserve ratios and set aside revenue for loan losses.WesBanco has spent the past two quarters building up their reserve ratio with a large amount being set aside in Q2 and a smaller amount in Q3 and currently has an above-peer ratio level.Turning to the dividend, WSBC currently pays out 32 cents per common share, and even in the coronavirus crisis it held that payment steady. The 52-cent payment annualizes to $1.32 per share, and gives a considerable yield of 5.16%.Raymond James analyst William Wallace is standing squarely with the bulls, noting: "PTPP earnings came in above expectations as noted, driven largely by lower operating expenses and higher fee income. Ultimately, we expect investors to remain honed in on credit in the nearer-term, where the company's bolstered reserve continues to provide us with a certain degree of comfort. All in, with shares trading essentially in line with peers, we continue to view the risk/reward dynamic positively given the company's solid capital levels (+9% TCE), along with both promising core earnings and deferral trends."Unsurprisingly, Wallace rates WesBanco an Outperform (i.e. Buy) along with a $29 price target. This target suggests a potential upside of 15% over the next year. (To watch Wallace’s track record, click here)Wallace is not the only fan of WSBC on Wall Street, as TipRanks analytics exhibit the stock as a Strong Buy. Based on 4 analysts tracked in the last 3 months, 3 rate the stock a Buy, while one says Hold. The 12-month average price target stands at $26.88, marking a 6.5% upside from where the stock is currently trading. (See WSBC stock analysis on TipRanks)CatchMark Timber (CTT)CatchMark Timber is an owner and operator of timberlands located in various parts of the country. The pandemic has not directly affected the timber industry. However, timber itself has maintained higher prices as home builders in the United States have seen increased demand. A lot of this new demand is generated from individuals moving out of cities into suburban areas.In the most recent quarter, Q3 2020 EBITDA for CatchMark Timber was above expectations coming in at $12.4MM versus $11MM consensus. The above-expectation earnings were attributed to cost controls from logging and hauling as well as SG&A costs. At the same time that CatchMark reported Q1 earnings, it also declared the Q3 dividend. The payment remains steady at 13.5 cents per share, yielding a solid 6%. The company has a 6-year history of keeping up its dividend payments, in all economic conditions.Adding to the good news, RBC Capital analyst Paul Quinn, rated 5-stars with TipRanks, has upgraded CTT to Outperform (i.e. Buy), while keeping his price target at $10. (To watch analyst track record, click here)As Quinn states, “CatchMark reported Q3 results that were in line with our forecasts but above consensus expectations. Although there have been minimal changes in business prospects over the last few months, CatchMark shares have moved in a wide range around our target price of $10. With the share price having pulled back to an attractive level and future prospects remaining solid, we are increasing our rating."Overall, CTT’s Strong Buy analyst consensus is derived from 3 "buy" and 1 "hold" ratings. Shares are priced at $8.91, and the average price target of $10.88 indicates potential for 22% growth. (See CTT stock analysis on TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
AMED AMEDISYS INC COM
SectorHealthcare
RecommendationsBuy
Buy Near55.13
Stop Loss46.55
Posted Date11/2/2008 12:00:00 AM
First resistance65.08
Second resistance67.29
Third resistance 
First Support55.03
Second Support46.55
Comments
11/2/2008 9:08:49 PM0) Amedisys Inc
1) com (AMED) Stock has given a buy signal, with rising moving average
2) Stockhastic and ADX also given a buy signal
3) Amedisys Inc
4) com (AMED) announced on 10/28/08 its profit grew 16 percent in the third quarter, and revenue jumped 78 percent
5) The company reported stronger admissions growth, and it was operating 150 more health agencies than a year earlier and also raised its full-year estimates, predicting greater profit and revenue Amedisys Inc
6) com (AMED) is a Home nursing company
7) As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Amedisys Inc
8) com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks
9) Due to Stock market and economic condition keep tight stop loss on all position
10) You can buy this Stock near $55.13
AMED       Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
Are Insiders Buying Amedisys, Inc. (NASDAQ:AMED) Stock?
(Mon, 23 Nov 2020 04:44:47 +0000)
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
Amedisys to Present at the Jefferies Virtual London Healthcare Conference
(Mon, 16 Nov 2020 21:30:00 +0000)
BATON ROUGE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020. The presentation will begin at 9:25 a.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,600 hospitals and 67,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, Tenn., Amedisys is a publicly held company. With 21,000 employees in 516 care centers within 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 415,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.comContact: Amedisys, Inc. Investor Relations 855.259.2046 IR@amedisys.com
Amedisys (AMED) Banks on Home Health & Hospice Amid Cost Woe
(Mon, 16 Nov 2020 15:27:03 +0000)
Amedisys (AMED) continues to benefit from the recent acquisitions of hospice care providers.
Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks
(Fri, 13 Nov 2020 13:15:46 +0000)
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Amedisys to Present at the Stephens Annual Investment Conference 2020
(Tue, 10 Nov 2020 21:00:00 +0000)
BATON ROUGE, La., Nov. 10, 2020 (GLOBE NEWSWIRE) --  Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Stephens Annual Investment Conference 2020 on Thursday, November 19, 2020. The presentation will begin at 2:00 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,600 hospitals and 67,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, Tenn., Amedisys is a publicly held company. With 21,000 employees in 516 care centers within 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 415,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.comContact: Amedisys, Inc. Investor Relations 855.259.2046 IR@amedisys.com


we recommends technically up trend Stocks for portfolio, Breakout stock, Penny Stocks and ETF on the base of technical analysis, news and global events analysis considering that you can plan your Stock Market Day Trading, Swing Trading, Stock trading, stock investing, portfolio, investment strategy.

Next Page >>   

 

























Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

Contact Us | Affiliate | Disclaimer | Feedback | Help | Site Map | RSS  RSS
All Rights Reserved © 2000-2006 Flyingstock.com
Technically up Trend Stocks for Portfolio | Swing Trading with support | resistance | stock research

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.